本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Vera Therapeutics, Inc.

35.05
+1.454.32%
盤後35.00-0.0500-0.14%19:47 EDT
成交量:379.67萬
成交額:1.31億
市值:25.14億
市盈率:-5.94
高:35.29
開:33.91
低:33.75
收:33.60
52周最高:56.05
52周最低:22.72
股本:7,171.39萬
流通股本:5,239.41萬
量比:2.91
換手率:7.25%
股息:- -
股息率:- -
每股收益(TTM):-5.8984
每股收益(LYR):-4.6644
淨資產收益率:-91.75%
總資產收益率:-46.76%
市淨率:6.16
市盈率(LYR):-7.51

資料載入中...

2026/09/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/11

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/11

重要事件披露

Form 8-K - Current report
2026/08/07

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/07/30

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/07/09

重要事件披露

Form 8-K - Current report
2026/07/07

重要事件披露

Form 8-K - Current report
2026/06/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/02

重要事件披露

Form 8-K - Current report
2026/05/27

重要事件披露

Form 8-K - Current report
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/07

重要事件披露

Form 8-K - Current report
2026/04/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/01

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/03/09

重要事件披露

Form 8-K - Current report
2026/02/27

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/02/26

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]